ArticleDiabetes spectrum : a publication of the American Diabetes Association2025
Racial Disparities in the Use of Automated Insulin Delivery Systems in Youth With Type 1 Diabetes.
Article in Diabetes spectrum : a publication of the American Diabetes Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAutomated insulin delivery (AID) systems improve glycemic outcomes in youth with type 1 diabetes and are now the recommended mode of insulin delivery. Previous studies highlighted racial disparities in the use of continuous glucose monitoring and insulin pump therapy. The purpose of this study was to evaluate the use of AID systems and A1C outcomes in youth with type 1 diabetes by race. RESEARCH DESIGN AND
methodsThis was a single-center cross-sectional study. We included youth and young adults with type 1 diabetes aged 2-21 years who had at least two clinic visits between December 2022 and December 2023. Demographics, diabetes device use, and A1C data were gathered from chart review, based on the latest office visit records available in the electronic medical record system for 2023.
resultsOut of 668 youth aged 3.1-19.9 years with type 1 diabetes, 435 (65%) were AID users. The prevalence of AID use was 70% (341 of 483) in White youth compared with 47% (60 of 129) among Black youth and 62% (34 of 55) among youth of other racial groups (
conclusionThese findings support the persistence of racial disparities in diabetes technology utilization.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.